Navigation Links
Arthritis and the Wnt Factor

An article by Nakamura et al., "Expression profiles and functional analyses of Wnt-related genes// in human joint disorders," will appear in the July issue of The American Journal of Pathology. The article revolves around the protein, Wnt. Wnt is a proto-oncogene since its disruption can lead to cancer in various organs. But current evidence might show that it is also involved in arthritic joint disease.

At present a through analysis of the Wnt gene family has been pending towards the progression of arthritis. A group of researchers at Shinshu University in Nagano, Japan have examined 19 members of the Wnt gene family. There study is to find out which gene is involved in arthritic joint disease. The study is being performed under the supervision of the assistant professor at the Department of Orthopedic Surgery, Dr, Shingeyuki Wakitani. The study also includes examination of joint tissues from patients who have undergone total knee replacements for rheumatoid arthritis (RA), osteoarthritis (OA), or non-arthritic injury.

The group had identified certain genes, which were upregulated in the arthritic knee tissues. These were Wnt-7b and Wnt –10a. The above was found with molecular methods, while protein expression studies reveal that only Wnt-7b was produced in arthritic joints, with strong protein localization to the synovium (or joint lining) and weak localization to cartilage and bone.

The author also examines whether inflammatory cytokines were produced in primary cartilage and synovial cells from arthritic versus normal joints. While OA cells did not differ from controls, primary RA cells produced TNF-a, IL-1? and IL-6 at levels 2- to 4-fold above controls. Importantly, this effect could be replicated in normal cells when they were engineered to express Wnt-7b, demonstrating the importance of Wnt-7b in the inflammatory response of RA.

Wnt-7b was noticed to be strongly upregulated within joints at sites of disease manifest ation mainly in synovium of RA but in synovium, cartilage, osteophyte, and bone of OA. Also findings show that Wnt-7b was recurrently found at sites of inflammation and elicited an inflammatory response, which are consistent with inflammation as a hallmark of RA disease.

This identifies Wnt-7b processing a role in arthritic processes. Arthritic diseases are known to manifest differently depending on the type, with RA displaying inflammation to the synovium and loss of cartilage and bone, and OA exhibiting a narrowing of joint space, loss of protective cartilage, and growth of bone cysts.
'"/>




Related medicine news :

1. Another ray of hope for Arthritis Sufferers
2. Naked DNA Vaccination May Conquer Arthritis and Multiple Sclerosis
3. B Vitamin protects and lowers toxicity of Arthritis Drug
4. FDA Approves New Arthritis Drug, Bextra
5. Risk Of Developing Arthritis
6. Arthritis Drug May Cause Liver Damage
7. Arthritis drug can prolong life
8. New treatment for Rheumatoid Arthritis
9. Important cause of Arthritis
10. Personality Impacts Arthritis
11. New Rheumatoid Arthritis Treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: